As seen in the current study, combined with blocking β-catenin activation and cyclin inhibition, ω-3 PUFAs significantly decreased anti-apoptotic genes, survivin, and Bcl-2, and increased apoptotic executors, leading to mitigation of AOM-initiated carcinogenic process. Here, BCL2 is linked to infectious otitis media.